The second virus was an attenuated, highly-inflammatory vaccinia virus expressing granulocyte-monocyte colony stimulating factor (VV-GMCSF), which has been studied previously in gliomas and generates an innate and adaptive anti-tumor immune response [35, 36]. The gene discussed is CSF2; the disease is glioma.